2000 Quarterly Earnings Reports
Pharmaceutical Sector Companies
Updated 09/12/03
Current publicly reported financial results (in $millions) for pharmaceutical-based companies. Please notethat all figures may reflect non-recurring charges, credits, gains or losses. Company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Abbott (ABT) | $3,353.2 | $693.0 | $3,370.2 | $685.2 | $3,317.9 | $654.4 | $3,705.0 | $753.4 | $13,746.3 | $2,786.0 |
| American Home Products (AHP) | $3,195.9 | $276.4 | $3,193.8 | $412.7 | $3,503.6 | $762.1 | $3,506.0 | ($3,822.0) | $13,399.3 | ($2,370.8) |
| AstraZeneca | $3,892.0 | $662.0 | $5,674.0 | $678.0 | $3,797.0 | $654.0 | $4,144.0 | $533.0 | $17,507.0 | $2,527.0 |
| Aventis (In Euros) | 5,276.0 | 258.0 | 5,815.0 | 374.0 | 5,429.0 | 126.0 | 5,784.0 | (610.0) | 22,304.0 | 148.0 |
| Bayer (in Euros) | 7,331.0 | 556.0 | 7,907.0 | 477.0 | 7,680.0 | 534.0 | 8,053.0 | 249.0 | 30,971.0 | 1,816.0 |
| Bristol-Myers Squibb (BMS) | $4,451.0 | $1,221.0 | $4,418.0 | $1,091.0 | $4,563.0 | $1,236.0 | $4,784.0 | $1,069.0 | $17,538.0 | $4,471.0 |
| Eli Lilly (LLY) | $2,451.1 | $845.5 | $2,621.6 | $666.2 | $2,812.0 | $778.8 | $2,978.0 | $767.3 | $10,862.7 | $3,057.8 |
| GlaxoSmithKline | $5,890.0 | $1,680.0 | $6,900.0 | $1,580.0 | $6,562.0 | $1,078.0 | $7,383.0 | $2,661.0 | $26,735.0 | $6,999.0 |
| Hoffmann-La Roche (SFr) | 14,808.00 | 6,203.00 | 13,864.00 | 2,444.00 | 28,672.00 | 8,647.00 | ||||
| ICN Pharmaceuticals (ICN) | $192.3 | $27.4 | $191.4 | $31.1 | $207.3 | $36.6 | $209.2 | $4.3 | $800.2 | $99.4 |
| Johnson & Johnson (JNJ) | $7,319.0 | $1,314.0 | $7,670.0 | $1,363.0 | $7,438.0 | $1,323.0 | $7,108.0 | $891.0 | $29,535.0 | $4,891.0 |
| Merck (MRK) | $8,851.4 | $1,499.6 | $9,477.1 | $1,721.7 | $10,568.0 | $1,836.0 | $11,467.0 | $1,764.0 | $40,363.5 | $6,821.3 |
| Novartis (SFr) | 6,730.00 | 1,634.00 | 7,240.00 | 1,762.00 | 7,329.00 | 1,557.00 | 7,813.00 | 1,558.00 | 29,112.00 | 6,511.00 |
| Pfizer (Revised) | $7,161.7 | ($204.0) | $6,989.0 | $1,150.0 | $7,158.0 | $1,361.0 | $8,105.0 | $1,420.0 | $29,413.7 | $3,727.0 |
| Pharmacia Corp | $4,172.0 | ($171.0) | $5,187.0 | $479.0 | $4,289.0 | $252.0 | $3,337.0 | $403.0 | $16,985.0 | $963.0 |
| Schering-Plough (SGP) | $2,389.0 | $628.0 | $2,626.0 | $634.0 | $2,383.0 | $591.0 | $2,418.0 | $571.0 | $9,816.0 | $2,424.0 |
| SmithKline Beecham | $3,199.0 | $580.0 | $3,188.0 | $552.0 | $3,252.0 | $638.0 | $9,639.0 | $1,770.0 | ||
| Totals | $56,517.6 | $9,051.9 | $61,506.1 | $11,043.9 | $59,850.8 | $11,200.9 | $59,144.2 | $7,015.0 | $236,340.6 | $38,165.7 |
